This Cancer Drug May Reduce Hearing Loss From Radiotherapy In Patients With Neurofibromatosis
According to a story from Medical Xpress, the addition of crizotinib with radiation therapy could help reduce hearing loss associated with the treatment in patients with neurofibromatosis II. Crizotinib is…